Extrait

To demonstrate safety and to determine most effective dose of subcutaneous nesiritide in patients with UHT.

Critère d'inclusion

• Uncontrolled hypertension (UHT, i.e. blood pressure ≥ 150/90, or ≥ 150/85 mm Hg in diabetic patients) despite treatment with at least two
• different classes of antihypertensive medications

Liens

• euctr